7Rivero A, Mora C, Muros M, et al. Pathogenic per- spectives for the role of inflammation in diabetic ne- phropathy[J]. Clin Sci,2009, 116(6) :479- 492.
8Navarro-Gonzdlez JF, Jarque A, Muros M, et al. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy[J]. Cytokine Growth Factor Rev, 2009,20 (2) :165-173.
9Rashid G, Benchetrit S, Fishman D, et al. Effect of ad- vanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide syn- thase by endothelial cells[J]. Kindney Int,2004,66 (3) : 1099-1106.
10Navarro JE, Mora C,GanezM, et al. Influence of renal involvement on peripheral blood mononuelear cell ex- pression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients[J].Nephml Di- al Transplant , 2008,23(3) :919-926.
